# Simvastatin Effect on Inflammation and Endothelial Function After Myocardial Infarction

> **NCT00906451** · PHASE4 · COMPLETED · sponsor: **Brasilia Heart Study Group** · enrollment: 58 (actual)

## Conditions studied

- Myocardial Infarction
- Inflammation
- Endothelial Dysfunction

## Interventions

- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT00906451
- **Lead sponsor:** Brasilia Heart Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2011-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00906451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00906451, "Simvastatin Effect on Inflammation and Endothelial Function After Myocardial Infarction". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00906451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*